Achieve Life Sciences ACHV
NASDAQ ACHV
$7.69 -0.06 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) EBITDA Margin (2010 - 2012)

Updated

Achieve Life Sciences' EBITDA Margin was -4.69% in FY2015.

Analysis

Achieve Life Sciences (ACHV) EBITDA Margin (2010 - 2012) Analysis & Trends

From FY2009 onward, Achieve Life Sciences has reported EBITDA Margin for 5 years.

  • EBITDA Margin shows a five-year change of +109.39 percentage points (FY2010 to FY2015).
  • The FY2015 figure marks the highest annual EBITDA Margin in data going back to FY2009.
  • Per Business Quant data, EBITDA Margin in earlier years was -104.49% in FY2012 (+161.12 pp) and -265.61% in FY2011 (-151.54 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Achieve Life Sciences 337.86 Mn 337.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -389.20%
Sep 30, 2012 126.61%
Jun 30, 2012 245.70%
Mar 31, 2012 -416.72%
Sep 30, 2011 350.60%
Mar 31, 2011 -434.20%
Sep 30, 2010 -142.06%
API Access

Achieve Life Sciences EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ACHV&period=max&api_key=YOUR_API_KEY